Clinically significant missense variants in human GALNT3, GALNT8, GALNT12, and GALNT13 genes: Intriguing in silico findings

Muhammad Ramzan M. Hussain, Jamal Nasir, Jumana Yousuf Al-Aama

Research output: Contribution to JournalArticlepeer-review


Aberrant glycosylation by N-acetylgalactosaminyl transferases (GALNTs) is a well-described pathological alteration that is widespread in hereditary diseases, prominently including human cancers, familial tumoral calcinosis and hyperostosis-hyperphosphatemia. In this study, we integrated different computational tools to perform the in silico analysis of clinically significant mutations (nsSNPs/single amino acid change) at both functional and structural levels, found in human GALNT3, GALNT8, GALNT12, and GALNT13 genes. From function and structure based insights, mutations encoding R162Q, T359K, C574G, G359D, R297W, D303N, Y396C, and D313N substitutions were concordantly predicted highly deleterious for relevant GALNTs proteins. From intriguing findings, T359K-GALNT3 was simulated with high contribution for disease susceptibility (tumor calcinosis) as compared to its partner variant T272K (Ichikawa et al. [2006] J. Clin. Endocrinol. Metab. 91:4472-4475). Similarly, the prediction of high damaging behavior, evolutionary conservation and structural destabilization for C574G were proposed as major contributing factors to regulate metabolic disorder underlying tumor calcinosis and hyperostosis-hyperphosphatemia syndrome. In case of R297W-GALNT12, prediction of highly deleterious effect and disruption in ionic interactions were anticipated with reduction in enzymatic activity, associated with bilateral breast cancer and primary colorectal cancers. The second GALNT12 mutation (D303N)-known splice variant-was predicted with disease severity as a result of decrease in charge density and buried behavior neighboring the catalytic B domain. In the lack of adequate in silico data about systematic characterization of clinically significant mutations in GALNTs genes, current study can be used as a significant tool to interpret the role of GALNTs reaction chemistry in disease-association risks in body. J. Cell. Biochem. 115: 313-327, 2014. © 2013 Wiley Periodicals, Inc.
Original languageEnglish
Pages (from-to)313-327
Number of pages15
JournalJournal of Cellular Biochemistry
Issue number2
Early online date12 Sep 2013
Publication statusPublished - 1 Feb 2014


  • Clinically Significant Mutations
  • GALNT12
  • GALNT13
  • GALNT3


Dive into the research topics of 'Clinically significant missense variants in human GALNT3, GALNT8, GALNT12, and GALNT13 genes: Intriguing in silico findings'. Together they form a unique fingerprint.

Cite this